SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004654
Filing Date
2021-11-16
Accepted
2021-11-15 20:10:36
Documents
66
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rani-20210930.htm   iXBRL 10-Q 3200422
2 EX-31.1 rani-ex31_1.htm EX-31.1 10110
3 EX-31.2 rani-ex31_2.htm EX-31.2 10135
4 EX-32.1 rani-ex32_1.htm EX-32.1 8025
  Complete submission text file 0000950170-21-004654.txt   9915663

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rani-20210930.xsd EX-101.SCH 60603
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rani-20210930_cal.xml EX-101.CAL 33577
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rani-20210930_pre.xml EX-101.PRE 423482
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rani-20210930_def.xml EX-101.DEF 340121
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rani-20210930_lab.xml EX-101.LAB 499793
10 EXTRACTED XBRL INSTANCE DOCUMENT rani-20210930_htm.xml XML 1546310
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Filer) CIK: 0001856725 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40672 | Film No.: 211413704
SIC: 2834 Pharmaceutical Preparations